Loading…
Loading…
| CRNX | Crinetics Pharmaceuticals, Inc. | $84.84 | $9.0B |
| PCVX | Vaxcyte, Inc. | $61.09 | $8.8B |
| CERE | Cerevel Therapeutics Holdings, Inc. | $44.96 | $8.2B |
| ELVN | Enliven Therapeutics, Inc. | $60.87 | $4.3B |
| GPCR | Structure Therapeutics Inc. | $49.35 | $2.8B |
| NUVB | Nuvation Bio Inc. | $6.96 | $2.4B |
| MLTX | MoonLake Immunotherapeutics | $15.62 | $1.3B |
| VTYX | Ventyx Biosciences, Inc. | $14.00 | $1.0B |
| ASMB | Assembly Biosciences, Inc. | $35.42 | $701.9M |
| CMPX | Compass Therapeutics, Inc. | $2.43 | $437.6M |
| KROS | Keros Therapeutics, Inc. | $11.12 | $355.8M |
| GRPH | Graphite Bio, Inc. | $3.18 | $185.2M |
| MOLN | Molecular Partners AG | $4.45 | $166.9M |
| CYT | Cyteir Therapeutics, Inc. | $3.02 | $108.7M |
| AVTE | Aerovate Therapeutics, Inc. | $2.68 | $77.7M |
| MNOV | MediciNova, Inc. | $1.48 | $72.8M |
| CSBR | Champions Oncology, Inc. | $4.92 | $68.4M |
| TIL | Instil Bio, Inc. | $7.83 | $53.1M |
| NXTC | NextCure, Inc. | $5.83 | $21.1M |
| ANEB | Anebulo Pharmaceuticals, Inc. | $0.33 | $13.5M |